PROTEOVANT THERAPEUTICS
Proteovant Therapeutics is a biotechnology company that utilizes protein degradation research in the development of medicines for diseases.
PROTEOVANT THERAPEUTICS
Social Links:
Industry:
Biotechnology Genetics Life Science Medical Pharmaceutical
Founded:
2021-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.proteovant.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins
Similar Organizations
BiotecEra
BiotecEra is a biotechnology company that focuses on microbial production of useful chemicals, particularly those used in pharmaceuticals.
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
EquiTech Therapeutics, LLC
EquiTech Therapeutics, LLC's is a pioneer in the forward development of CRISPR-Cas9 genome editing for equine diseases and therapies.
Instant Chemistry
Instant Chemistry is a biotechnology company that uses personal genomics to determine compatibility for singles and couples.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Verio Therapeutics
Verio Therapeutics is a biotechnology company that is developing drug candidates targeting the activation of endogenous stem cells.
Current Employees Featured
More informations about "Proteovant Therapeutics"
Collaboration to Advance Novel Therapeutics Announce Strategic
Proteovant integrates its foundational degrader portfolio, internal deep drug hunting expertise, โฆSee details»
SK Group acquires Proteovant Therapeutics - Crunchbase
Proteovant Therapeutics Proteovant Therapeutics is a biotechnology company that utilizes โฆSee details»
Blueprint Medicines and Proteovant Therapeutics Announce โฆ
-- Proteovant to receive a $20 million upfront payment and up to an additional $632 million in โฆSee details»
Proteovant Therapeutics - Products, Competitors, Financials, โฆ
Proteovant Therapeutics operates as a protein degradation company. The company uses its โฆSee details»
Proteovant Therapeutics - Contacts, Employees, Board Members, โฆ
Proteovant Therapeutics is a biotechnology company that utilizes protein degradation research โฆSee details»
Proteovant Therapeutics, Inc. (Proteovant Therapeutics, Inc.) - ่ฏ็ฉ โฆ
Within program-specific costs, the decrease of $10.0 million was primarily driven by a decrease โฆSee details»
SK Inc.-backed Companies VantAI and Proteovant Therapeutics โฆ
Apr 18, 2022 Proteovant and its sister company, VantAI, both recently announced plans to โฆSee details»
Proteovant Therapeutics - VentureRadar
Proteovant is leveraging targeted protein degradation to discover and develop transformative โฆSee details»
The Vibrant Philly Biotech Scene: Proteovant โฆ
Oct 26, 2021 Proteovant is expanding its discovery and development teams and has multiple positions in biology, chemistry, biochemistry, DMPK, bioinformatics and CMC at many levels. Our R&D organization is located close to major โฆSee details»
SK Life Science Labs | LinkedIn
SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, is a U.S. biotech company focused on the discovery of transformative medicines through targeted protein degradation (TPD).See details»
Blueprint marks protein degrader path in $632M biobucks pact โฆ
Feb 28, 2022 Proteovant can co-develop and co-commercialize the second of the two โฆSee details»
Proteovant Therapeutics | Life Sciences PA
Proteovant is a pioneering protein degradation company focused on discovering and โฆSee details»
Blueprint Medicines and Proteovant Therapeutics Announce โฆ
Mar 2, 2022 Under the terms of the agreement, Proteovant will receive a $20 million upfront โฆSee details»
Blueprint Medicines and Proteovant Therapeutics Announce โฆ
Feb 28, 2022 About Proteovant Therapeutics Proteovant is leveraging the process of protein โฆSee details»
Proteovant Therapeutics to Present Preclinical Data from Estrogen ...
Mar 14, 2023 PVTX-321 and PVTX-405 Achieve Development Candidate NominationNEW โฆSee details»
SK Biopharmaceuticals' Proteovant Therapeutics Presents โฆ
Sep 27, 2023 SK Biopharmaceuticals and Proteovant Therapeutics are discovering and โฆSee details»
Blueprint Medicines, Proteovant Therapeutics Collaborate on โฆ
Mar 2, 2022 Proteovant has the option to co-develop and co-commercialize the second of the โฆSee details»
Proteovant Therapeutics to Present Preclinical Data from
NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Proteovant Therapeutics, a Roivant โฆSee details»
SK Biopharmaceuticalsโ Proteovant Therapeutics Presents
Oct 12, 2023 Proteovant Therapeutics exploits the ubiquitin-protease system (UPS) to โฆSee details»